Abstract
Three thousand one hundred and twenty men out of the target population of 22, 195 men underwent PSA (prostatic specific antigen) determinations as the mass screening test for CAP (prostatic cancer). Three hundred and sixty men showed high (≥ 4.0 ng/ml) PSA values and proceeded to the secondary examinations. Prostatic biopsies were done on two hundred and twelve men, 35 % (74) of them had CAP. The detection rate was 2.4 % of the total examinees.
Key words
Prostatic cancer - prostatic specific antigen - mass screening - prostatic biopsy
References
-
1
Imai K, Ichinose Y, Kubota Y, Yamanaka H, Sato J.
Diagnostic significance of prostate specific antigen and development of a mass screening system for prostate cancer.
J Urol.
1995;
154
1085-1089
-
2
Nishimatsu H, Kawamura T, Homma Y, Kitamura T, Kawabe K.
The practical use of prostatic antigen in mass screening program for prostate cancer.
Jpn J Urol Surgery.
1998;
11
932-937 (in Japanese)
Kazuki Kawabe,M. D.
Tokyo Teishin Hospital
2/14/23 Fujimi, Chiyoda-ku, Tokyo 1028798
Japan
Phone: +81-3-5214-7000
Fax: +81-3-5214-1384
Email: kkawabe@tth-japanpost.jp
